Editorial: Recent Advances in Cardiotoxicity Testing
- PMID: 34819868
- PMCID: PMC8606750
- DOI: 10.3389/fphar.2021.798189
Editorial: Recent Advances in Cardiotoxicity Testing
Keywords: cancer; cardiooncology; heart; heart slices; hiPS cardiomycytes; toxicicity.
Conflict of interest statement
TM holds equities in Tenaya Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Recent Advances in Cardiotoxicity Testing
References
-
- Asnani A., Moslehi J. J., Adhikari B. B., Baik A. H., Beyer A. M., de Boer R. A., et al. (2021). Preclinical Models of Cancer Therapy-Associated Cardiovascular Toxicity: A Scientific Statement from the American Heart Association. Circ. Res. 129, e21–e34. 10.1161/RES.0000000000000473 - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources